BCX4161

· BioCryst Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BCX4161, covering 2014-08-15 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks [Phase 2, Phase 3]